The Risk of Switch to Mania in Patients With Bipolar Disorder During Treatment With an Antidepressant Alone and in Combination With a Mood Stabilizer
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study examined the risk of antidepressant-induced manic switch in patients with bipolar disorder treated either with antidepressant monotherapy or with an antidepressant in conjunction with a mood stabilizer. METHOD: Using Swedish national registries, the authors identified 3,240 patients with bipolar disorder who started treatment with an antidepressant and had no antidepressant treatment during the previous year. Patients were categorized into those receiving antidepressant monotherapy and those receiving an antidepressant plus a mood stabilizer. A within-individual design was used to control for confounding by disorder severity, genetic makeup, and early environmental factors. Cox regression analyses conditioned on individual were used to compare the rate of mania 0-3 months and 3-9 months after the start of antidepressant treatment with a preceding non-treatment period. RESULTS: Nearly 35% of the patients were treated with antidepressant monotherapy. The increased risk of treatment-emergent mania was confined to patients on antidepressant monotherapy (hazard ratio=2.83, 95% CI=1.12, 7.19). Among patients treated with a concurrent mood stabilizer, no acute change in risk of mania was observed during the 3 months after the start of antidepressant treatment (hazard ratio=0.79, 95% CI=0.54, 1.15), and a decreased risk was observed during the period 3-9 months after treatment initiation (hazard ratio=0.63, 95% CI=0.42, 0.93). CONCLUSIONS: In this national registry study, antidepressant monotherapy was associated with an increased risk of mania. However, no risk of mania was seen in patients receiving an antidepressant while treated with a mood stabilizer. The results highlight the importance of avoiding antidepressant monotherapy in the treatment of bipolar disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antidepressants should not be used as monotherapy in patients with BDI depression, as available trials do not support their efficacy and there are concerns about their safety in terms of mood switching (level 2 negative).260, 289, 290, 291”
In the citing paper
“Antidepressants should not be used as monotherapy in patients with BDI depression, as available trials do not support their efficacy and there are concerns about their safety in terms of mood switching (level 2 negative).260, 289, 290, 291”
In the citing paper
“In a s Swedish national patient registry study of patients with BD and ADHD, methylphenidate monotherapy significantly increased the risk of mania, while those patients treated concurrently with a mood stabilizer experienced a significantly reduced risk of mania when methylphenidate was employed.289”
In the citing paper
“In a s Swedish national patient registry study of patients with BD and ADHD, methylphenidate monotherapy significantly increased the risk of mania, while those patients treated concurrently with a mood stabilizer experienced a significantly reduced risk of mania when methylphenidate was employed.289”
In the citing paper
“However, they may destabilize mood in people with bipolar disorder, especially if used without a mood stabilizer (Viktorin et al. 2014; McGirr et al. 2016).”
From Cognitive behavioural therapy for social anxiety disorder in people with bipolar disorder: a case series (2024) · cites this paper as Viktorin et al. 2014
Citations
Cites
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055 · cited 1×
“Patients with bipolar disorder were identified using the National Patient Register, which includes all Swedish psychiatric inpatient admissions since 1973 and all psychiatric outpatient admissions, excluding those in primary care, since 2001 (29).”
MethodThe Swedish personal identity number: possibilities and pitfalls in healthcare and medical research
Ludvigsson, J. F., Otterblad-Olausson, P., Pettersson, B. U., & Ekbom, A. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9350-y · Cited by 2,403 · cited 1×
“Using the unique individual Swedish national registration number assigned to each individual at birth and to immigrants on arrival, we linked Swedish national registries with high accuracy (28).”
BackgroundThe Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Wettermark, B., Hammar, N., MichaelFored, C., Leimanis, A., Otterblad Olausson, P., Bergman, U., Persson, I., Sundström, A., Westerholm, B., & Rosén, M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1294 · Cited by 1,887 · cited 1×
“To ascertain the use of prescribed drugs among these patients, we used the Swedish Prescribed Drug Register (SPDR), which contains data on all dispensed prescribed drugs since July 2005 (31).”
MethodJudd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Endicott, J., Maser, J. D., Solomon, D. A., Leon, A. C., & Keller, M. B. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.261 · Cited by 1,243
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“evidence for unipolar depression (8), only a handful of”
BackgroundPacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020185 · Cited by 770 · cited 1×
“This study thus lends further support to the need for caution when using antidepressant monotherapy to treat bipolar depressive episodes because of the risk of treatment-emergent mania, an approach that is in accord with recent recommendations from the International Society for Bipolar Disorders on antidepressant use…”
ResultSelf-citationAntidepressant-induced mania and cycle acceleration: a controversy revisited
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1130 · Cited by 608
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Leon, A. C., Solomon, D. A., Coryell, W., Maser, J. D., & Keller, M. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.12.1322 · Cited by 577 · cited 1×
“are a major cause of psychosocial disability (6).”
BackgroundInduction of Mania with Selective Serotonin Re-uptake Inhibitors and Tricyclic Antidepressants
Peet, M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.4.549 · Cited by 474
Prien, R. F. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200030104017 · Cited by 448
Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S. L., Keck, P. E., Kupka, R. W., Denicoff, K. D., Nolen, W. A., Grunze, H., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.232 · Cited by 419
Rapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants
Wehr, T. A. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050065007 · Cited by 408 · cited 1×
“creasedmood cycling in bipolar patients (10).”
Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder 1
Kupka, R. W., Altshuler, L. L., Nolen, W. A., Suppes, T., Luckenbaugh, D. A., Leverich, G. S., Frye, M. A., Keck, P. E., McElroy, S. L., Grunze, H., et al. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00467.x · Cited by 397
Antidepressant‐induced mania: an overview of current controversies
Goldberg, J. F., & Truman, C. J. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00067.x · Cited by 311 · cited 1×
“To allow for assessment of both acute and longer-term effects, interaction terms with split follow-up time (0–3 months, 3–9 months) were included in the statistical model (32).”
MethodPatterns of Psychotropic Drug Prescription for U.S. Patients With Diagnoses of Bipolar Disorders
Baldessarini, R. J., Leahy, L., Arcona, S., Gause, D., Zhang, W., & Hennen, J. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.1.85 · Cited by 280 · cited 1×
“scribed and constitute 50% of all prescribed psychotropic medication in bipolar disorder (7).”
BackgroundMania associated with antidepressant treatment: comprehensive meta‐analytic review
Tondo, L., Vázquez, G., & Baldessarini, R. J. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01514.x · Cited by 256 · cited 2×
“(27), who found that mood stabilizers did not protect against treatment-emergent mania during antidepressant treatment.”
BackgroundResultYoung, L. T., Joffe, R. T., Robb, J. C., MacQueen, G. M., Marriott, M., & Patelis-Siotis, I. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.124 · Cited by 211
Sellgren, C., Landén, M., Lichtenstein, P., Hultman, C. M., & Långström, N. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01747.x · Cited by 208 · cited 1×
“An algorithm based on less strict inclusion criteria for bipolar disorder has been demonstrated to yield a high positive predictive value (30).”
MethodSelf-citationAntidepressant-Induced Mania in Bipolar Patients: Identification of Risk Factors
Henry, C., Sorbara, F., Lacoste, J., Gindre, C., & Leboyer, M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0406 · Cited by 177 · cited 1×
“(24), who found a significantly decreased risk of switching when a mood stabilizer was coadministered with a tricyclic antidepressant compared with a tricyclic alone.”
BackgroundSwitch from Depression to Mania – A Record Study over Decades between 1920 and 1982
Angst, J. (1985) · Psychopathology · doi:10.1159/000284227 · Cited by 177
New treatment guidelines for acute bipolar depression: A systematic review
Nivoli, A. M. A., Colom, F., Murru, A., Pacchiarotti, I., Castro-Loli, P., González-Pinto, A., Fountoulakis, K. N., & Vieta, E. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.05.018 · Cited by 161 · cited 1×
“Guidelines differ with respect to second-line treatments (and regional differences can be observed as well) (22), although some endorse the use of antidepressants in combination with antimanic agents, particularly if used for limited periods.”
BackgroundThe Induction of Mania: A Natural History Study With Controls
Lewis, J. L. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290030041007 · Cited by 150
Suicide Attempts in Bipolar Patients
Lopez, P., Mosquera, F., de Leon, J., Gutierrez, M., Ezcurra, J., Ramurez, F., & Gonzalez-Pinto, A. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1208 · Cited by 145 · cited 1×
“cant risk of suicide (5), and lingering depressive symptoms”
BackgroundBipolar Depression and Antidepressant-Induced Mania: A Naturalistic Study
Boerlin, H. L., Gitlin, M. J., Zoellner, L. A., & Hammen, C. L. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0706 · Cited by 142 · cited 1×
“(26) compared mood-stabilizer treatment to antidepressant treatment in a small number of patients and did not find any difference in manic symptoms between the groups (14, 26).”
ResultTruman, C. J., & Goldberg, J. F. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1002 · Cited by 137
A Controlled Trial of Imipramine in Treatment of Depressive States
Ball, J. R. B., & Kiloh, L. G. (1959) · BMJ · doi:10.1136/bmj.2.5159.1052 · Cited by 127
Bottlender, R., Rudolf, D., Strauß, A., & Möller, H. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00172-5 · Cited by 115
Risk Factors for Antidepressant-Related Switch to Mania
Valentí, M., Pacchiarotti, I., Bonnín, C. M., Rosa, A. R., Popovic, D., Nivoli, A. M. A., Goikolea, J. M., Murru, A., Undurraga, J., Colom, F., et al. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07166 · Cited by 86
The Treatment of Depressive States with Imipramine Hydrochloride (Tofranil)
Leyberg, J. T., & Denmark, J. C. (1959) · Journal of Mental Science · doi:10.1192/bjp.105.441.1123 · Cited by 61 · cited 1×
“could increase the risk of abnormal mood elevation (11, 12).”
BackgroundMaj, M., Pirozzi, R., Magliano, L., & Bartoli, L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1711 · Cited by 61 · cited 1×
“worsened long-term outcome (9), and some studies report”
BackgroundBipolar depression: Diagnostic and treatment considerations
Thase, M. E. (2006) · Development and Psychopathology · doi:10.1017/s0954579406060585 · Cited by 52 · cited 1×
“toms that dominate the course of the illness (1).”
BackgroundSelf-citationBipolar disorder, antidepressants and induction of hypomania or mania. A systematic review
Visser, H. M., & Van Der Mast, R. C. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510029885 · Cited by 47
The Treatment of Depressive States with Imipramine Hydrochloride
Kenning, I. S., Richardson, N. L., & Tucker, F. G. (1960) · Canadian Psychiatric Association Journal · doi:10.1177/070674376000500114 · Cited by 28
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
“Furthermore, in a fourth trial, there was also sugges on of efficacy based on some secondary measures (289).”
BackgroundGoodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
“Recent linkage of clinical data with prescribing data in Sweden suggested that monotherapy with drugs for unipolar depression is indeed associated with manic relapse in bipolar I patients, compared with combination with a mood stabilizer (Viktorin et al., 2014).”
Hashimoto, K. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12902 · Cited by 335
“The switch to mania from depression is an important side-effect of using antidepressants to treat bipolar depression.(49,50) Although the use of ketamine might produce adverse reactions (i.”
BackgroundPharmacological treatment of adult bipolar disorder
Baldessarini, R. J., Tondo, L., & Vázquez, G. H. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0044-2 · Cited by 272
Rhee, T. G., Olfson, M., Nierenberg, A. A., & Wilkinson, S. T. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.19091000 · Cited by 244
Metadata
- Authors
- Viktorin, A., Lichtenstein, P., Thase, M. E., Larsson, H., Lundholm, C., Magnusson, P. K. E., & Landén, M.
- Affiliations
- Eli Lilly (United States) (US)
- Karolinska Institutet (SE)
- Corresponding author
- Viktorin, Alexander
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2014-10
- Volume
- 171
- Issue
- 10
- Pages
- 1067-1073
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2150146224
- Cited by
- 246
- References
- 34
- Citations by year
- 2026: 18 · 2025: 22 · 2024: 24 · 2023: 19 · 2022: 16 · 2021: 23 · 2020: 25 · 2019: 17 · 2018: 23 · 2017: 18 · 2016: 20 · 2015: 16 · 2014: 5
- FWCI
- 15.01
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Open Archive (Karolinska Institutet) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- bipolar disorder, antidepressant-induced mania, antidepressant monotherapy, mood stabilizers, treatment-emergent mania, antidepressant safety
- MeSH terms
- Adult, Affect, Antidepressive Agents, Bipolar Disorder, Drug Therapy, Combination, Female, Humans, Male, Psychotropic Drugs, Registries, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.